Mulders P - Search Results

1

A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.

Albiges L, Choueiri T, Escudier B, Galsky M, George D, Hofmann F, Lam T, Motzer R, Mulders P, Porta C, Powles T, Sternberg C, Bex A. Albiges L, et al. Among authors: mulders p. Eur Urol. 2015 Jan;67(1):100-110. doi: 10.1016/j.eururo.2014.04.006. Epub 2014 May 1. Eur Urol. 2015. PMID: 24841777 Review.

2

Value of biochemical markers in the management of disseminated prostatic cancer.

Mulders PF, Fernandez del Moral P, Theeuwes AG, Oosterhof GO, van Berkel HT, Debruyne FM. Mulders PF, et al. Eur Urol. 1992;21(1):2-5. doi: 10.1159/000474790. Eur Urol. 1992. PMID: 1376692

3

Intravesical therapy in superficial bladder cancer.

Witjes JA, Mulders PF, Debruyne FM. Witjes JA, et al. Among authors: mulders pf. Urology. 1994 Feb;43(2 Suppl):2-5; discussion 6. doi: 10.1016/0090-4295(94)90211-9. Urology. 1994. PMID: 8116130

4

Immunotherapy for renal cell carcinoma.

Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Bleumer I, et al. Among authors: mulders pf. Eur Urol. 2003 Jul;44(1):65-75. doi: 10.1016/s0302-2838(03)00191-x. Eur Urol. 2003. PMID: 12814677 Review.

5

Targeting of adenovirus to human renal cell carcinoma cells.

Jongmans W, van den Oudenalder K, Tiemessen DM, Molkenboer J, Willemsen R, Mulders PF, Oosterwijk E. Jongmans W, et al. Urology. 2003 Sep;62(3):559-65. doi: 10.1016/s0090-4295(03)00378-9. Urology. 2003. PMID: 12946777

6

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.

Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. Han KR, et al. Among authors: mulders pf. J Urol. 2003 Dec;170(6 Pt 1):2221-4. doi: 10.1097/01.ju.0000096049.64863.a1. J Urol. 2003. PMID: 14634383

7

Monoclonal antibody therapy of kidney cancer.

Oosterwijk E, Brouwers A, Boerman OC, Larson SM, Old LJ, Mulders P, Divgi CR. Oosterwijk E, et al. Among authors: mulders p. Cancer Treat Res. 2003;116:199-212. doi: 10.1007/978-1-4615-0451-1_12. Cancer Treat Res. 2003. PMID: 14650834 Review. No abstract available.

8

Novel treatments for metastatic renal cell carcinoma.

van Spronsen DJ, Mulders PF, De Mulder PH. van Spronsen DJ, et al. Among authors: mulders pf. Crit Rev Oncol Hematol. 2005 Sep;55(3):177-91. doi: 10.1016/j.critrevonc.2005.04.002. Crit Rev Oncol Hematol. 2005. PMID: 15979888 Review.

9

Novel treatment strategies in clear-cell metastatic renal cell carcinoma.

van Spronsen DJ, de Weijer KJ, Mulders PF, De Mulder PH. van Spronsen DJ, et al. Among authors: mulders pf. Anticancer Drugs. 2005 Aug;16(7):709-17. doi: 10.1097/01.cad.0000167901.58877.a3. Anticancer Drugs. 2005. PMID: 16027518 Review.

10

A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma.

Bleumer I, Oosterwijk E, Oosterwijk-Wakka JC, Völler MC, Melchior S, Warnaar SO, Mala C, Beck J, Mulders PF. Bleumer I, et al. Among authors: mulders pf. J Urol. 2006 Jan;175(1):57-62. doi: 10.1016/S0022-5347(05)00040-6. J Urol. 2006. PMID: 16406869 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

585 results

Search Page